Evidence map›Paper›PMID 28775351›Full record

ArticleNature nanotechnology2017

Setting the stage for debating the roles of risk assessment and life-cycle assessment of engineered nanomaterials.

Jeroen B Guinée, Reinout Heijungs, Martina G Vijver, Willie J G M Peijnenburg

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature nanotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Digesting the alphabet soup of LCA.The international journal of life cycle assessment · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeroen B GuinéeInstitute of Environmental Sciences (CML), Leiden University, PO Box 9518, 2300 RA Leiden, The Netherlands.ORCID 0000-0003-2558-6493
Reinout HeijungsInstitute of Environmental Sciences (CML), Leiden University, PO Box 9518, 2300 RA Leiden, The Netherlands.ORCID 0000-0002-0724-5962
Martina G VijverInstitute of Environmental Sciences (CML), Leiden University, PO Box 9518, 2300 RA Leiden, The Netherlands.
Willie J G M PeijnenburgInstitute of Environmental Sciences (CML), Leiden University, PO Box 9518, 2300 RA Leiden, The Netherlands.ORCID 0000-0003-2958-9149
Leiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although technological and environmental benefits are important stimuli for nanotechnology development, these technologies have been contested from an environmental point of view. The steady growth of applications of engineered nanomaterials has heated up the debate on quantifying the environmental repercussions. The two main scientific methods to address these environmental repercussions are risk assessment and life-cycle assessment. The strengths and weaknesses of each of these methods, and the relation between them, have been a topic of debate in the world of traditional chemistry for over two decades. Here we review recent developments in this debate in general and for the emerging field of nanomaterials specifically. We discuss the pros and cons of four schools of thought for combining and integrating risk assessment and life-cycle assessment and conclude with a plea for action.

Identifiers

PMID28775351
OpenAlexW2744919936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.